Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Meduloc is a privately held orthopedic medical device company developing and commercializing minimally invasive intramedullary implants for fracture fixation. Its core technology is a flexible nitinol intramedullary implant platform designed to provide fracture reduction, rotational stability, and fixation control while preserving soft tissue and avoiding joint violation in certain applications. The company focuses on small and long-bone fractures across upper- and lower-extremity indications, including both adult and pediatric use cases. Founded by orthopedic hand surgeons together with Cor Medical Ventures, Meduloc has advanced from product development and regulatory clearance into controlled commercialization. The company positions its system as a joint-preserving, soft tissue-sparing alternative for surgeons treating fractures such as metacarpal, metatarsal, phalange, clavicle, radius, ulna, and fibula injuries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Meduloc.